BMS-986165 Capsule

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	5

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-001203-79-ES (EUCTR)	11/06/2019	30/04/2019	A clinical study to test the efficacy and safety of BMS-986165in Subjects with Systemic Lupus Erythe ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS- ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: LLT;Classification code 10042947;Term: Syst ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165	Bristol-Myers Squibb International Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 2	United States;Taiwan;Spain;Russian Federation;Israel;Colombia;France;Hungary;Mexico;Canada;Argentina ...
2	EUCTR2017-001203-79-DE (EUCTR)	12/12/2018	27/02/2018	A clinical study to test the efficacy and safety of BMS-986165in Subjects with Systemic Lupus Erythe ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS- ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: LLT;Classification code 10042947;Term: Syst ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Hungary;Mexico;Canada;Argentina;Poland ...
3	EUCTR2017-001203-79-PL (EUCTR)	05/01/2018	03/11/2017	A clinical study to test the efficacy and safety of BMS-986165in Subjects with Systemic Lupus Erythe ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS- ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: LLT;Classification code 10042947;Term: Syst ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Hungary;Mexico;Argentina;Poland;Brazil ...
4	EUCTR2017-001203-79-HU (EUCTR)	04/12/2017	04/10/2017	A clinical study to test the efficacy and safety of BMS-986165in Subjects with Systemic Lupus Erythe ...	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS- ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: LLT;Classification code 10042947;Term: Syst ...	Product Name: BMS-986165 Product Code: BMS-986165 INN or Proposed INN: BMS-986165	Bristol-Myers Squibb international Corporation	NULL	Not Recruiting			Female: yes Male: yes	400	Phase 2	United States;Taiwan;Spain;Ukraine;Russian Federation;Israel;Colombia;France;Hungary;Mexico;Argentin ...
5	NCT03254784 (ClinicalTrials.gov)	September 13, 2017	17/8/2017	A Study to Evaluate BMS-986165Tablet Formulation Relative to BMS-986165 CapsuleFormulation and the E ...	A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of B ...	Systemic Lupus Erythematosus;Arthritic Psoriasis;Psoriasis;Inflammatory Bowel Diseases	Drug: BMS-986165 Capsule;Drug: BMS-986165 Tablet	Bristol-Myers Squibb	NULL	Completed	18 Years	50 Years	All	49	Phase 1	United States;Netherlands

First Previous1Next Last